• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基层医疗视角以及嵌入电子健康记录的多学科机构前列腺癌筛查算法的实施

Primary care perspective and implementation of a multidisciplinary, institutional prostate cancer screening algorithm embedded in the electronic health record.

作者信息

Aminsharifi Alireza, Schulman Ariel, Anderson John, Fish Laura, Oeffinger Kevin, Shah Kevin, Sze Christina, Tay Kae J, Tsivian Efrat, Polascik Thomas J

机构信息

Division of Urological Surgery, Durham, NC; Department of Urology Shiraz University of Medical Sciences Shiraz, Iran; Duke Cancer Institute, Duke University, Durham, NC.

Division of Urological Surgery, Durham, NC.

出版信息

Urol Oncol. 2018 Nov;36(11):502.e1-502.e6. doi: 10.1016/j.urolonc.2018.07.016. Epub 2018 Aug 28.

DOI:10.1016/j.urolonc.2018.07.016
PMID:30170982
Abstract

PURPOSE

In response to controversy regarding prostate cancer (CaP) screening recommendations, a consolidated Duke Cancer Institute (DCI) multidisciplinary algorithm for CaP screening was developed and implemented. We conducted an online survey within the year following its implementation to assess primary care provider (PCP) attitudes and adoption as well as to evaluate how this program affects screening rates.

METHODS

A web-based 18-item survey was programmed and was electronically mailed to practicing PCPs at clinics affiliated with the Duke Primary Care system. The survey assessed provider practices and attitudes regarding CaP screening, factors that influenced their general screening recommendations and the confidence related to communicating with patients about screening. The rate of PSA screening before and after implementation of the algorithm was reported across age and race categories.

RESULTS

In sum, 94 of 106 respondents (88.6%) reported discussing the benefits and harms of screening and let their patients decide (52.8%) or recommended for (31.1%) or against (4.7%) screening. Three-fourths of respondents followed a specific panel recommendation such as the United States Preventative Services Task Force (USPSTF) (48.1%), DCI (20%), or the American Urological Association (AUA) (7.4%) guidelines. After integrating this algorithm into the electronic health record, the rate of prostate screening increased between 11% and 20.4% and 15.6% and 16.4% among different age and race categories, respectively. Overall, 79.2% of PCPs felt very confident regarding their ability to communicate the topic of CaP screening with patients.

CONCLUSION

The DCI multidisciplinary CaP screening algorithm was well adopted among PCPs shortly after its implementation. The rate of screening increased among all age and race categories thereafter. The majority of PCPs involved in this survey felt confident regarding their CaP screening knowledge and most discuss this topic with patients in a shared decision-making model.

摘要

目的

针对前列腺癌(CaP)筛查建议引发的争议,制定并实施了杜克癌症研究所(DCI)综合多学科CaP筛查算法。在实施后的一年内,我们开展了一项在线调查,以评估初级保健提供者(PCP)的态度和采用情况,并评估该计划如何影响筛查率。

方法

编制了一份基于网络的包含18个条目的调查问卷,并通过电子邮件发送给杜克初级保健系统附属诊所的执业PCP。该调查评估了提供者关于CaP筛查的实践和态度、影响其一般筛查建议的因素以及与患者沟通筛查相关问题的信心。报告了算法实施前后不同年龄和种族类别的PSA筛查率。

结果

总体而言,106名受访者中有94名(88.6%)报告讨论了筛查的益处和危害,并让患者自行决定(52.8%),或建议进行筛查(31.1%)或反对筛查(4.7%)。四分之三的受访者遵循特定的专家组建议,如美国预防服务工作组(USPSTF)(48.1%)、DCI(20%)或美国泌尿外科学会(AUA)(7.4%)的指南。将该算法整合到电子健康记录中后,不同年龄和种族类别中的前列腺筛查率分别提高了11%至20.4%和15.6%至16.4%。总体而言,79.2%的PCP对自己与患者沟通CaP筛查话题的能力非常有信心。

结论

DCI多学科CaP筛查算法在实施后不久便被PCP广泛采用。此后,所有年龄和种族类别的筛查率均有所提高。参与本次调查的大多数PCP对自己的CaP筛查知识充满信心,并且大多数以共同决策模式与患者讨论这一话题。

相似文献

1
Primary care perspective and implementation of a multidisciplinary, institutional prostate cancer screening algorithm embedded in the electronic health record.基层医疗视角以及嵌入电子健康记录的多学科机构前列腺癌筛查算法的实施
Urol Oncol. 2018 Nov;36(11):502.e1-502.e6. doi: 10.1016/j.urolonc.2018.07.016. Epub 2018 Aug 28.
2
Prostate cancer screening practices in a large, integrated health system: 2007-2014.大型综合医疗系统中的前列腺癌筛查实践:2007 - 2014年
BJU Int. 2017 Aug;120(2):257-264. doi: 10.1111/bju.13793. Epub 2017 Feb 26.
3
Seniority of primary care physicians is associated with a decrease in PSA ordering habits in the years surrounding the United States Preventative Services Task Force recommendation against PSA screening.在美国预防服务工作组发布反对前列腺特异性抗原(PSA)筛查的建议前后几年,初级保健医生的资历与PSA检测开单习惯的减少有关。
Urol Oncol. 2018 Nov;36(11):500.e21-500.e27. doi: 10.1016/j.urolonc.2018.07.011. Epub 2018 Sep 18.
4
Provider Perceptions of an Electronic Health Record Prostate Cancer Screening Tool.医疗机构对电子健康记录前列腺癌筛查工具的看法。
Appl Clin Inform. 2024 Mar;15(2):282-294. doi: 10.1055/s-0044-1782619. Epub 2024 Apr 10.
5
Primary Care Physicians Beliefs about Prostate-Specific Antigen Evidence Uncertainty, Screening Efficacy, and Test Use.初级保健医生对前列腺特异性抗原证据不确定性、筛查效果和检测使用的看法。
J Natl Med Assoc. 2018 Oct;110(5):491-500. doi: 10.1016/j.jnma.2017.12.007. Epub 2018 May 7.
6
[Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].[使用前列腺特异性抗原进行前列腺癌筛查:普通医生和检验医生的观点]
Semergen. 2018 Sep;44(6):409-419. doi: 10.1016/j.semerg.2018.02.001. Epub 2018 Mar 21.
7
Revisiting Prostate Cancer Screening Practices Among Vermont Primary Care Physicians.重新审视佛蒙特州初级保健医生的前列腺癌筛查实践。
J Community Health. 2018 Feb;43(1):33-37. doi: 10.1007/s10900-017-0384-x.
8
Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.前列腺特异性抗原筛查前列腺癌:初级保健医生的知识、态度和利用情况。
Urol Oncol. 2012 Mar-Apr;30(2):155-60. doi: 10.1016/j.urolonc.2009.12.019. Epub 2010 Aug 25.
9
PSA screening: determinants of primary-care physician practice patterns.PSA 筛查:基层医疗医师实践模式的决定因素。
Prostate Cancer Prostatic Dis. 2012 Jun;15(2):189-94. doi: 10.1038/pcan.2011.59. Epub 2011 Nov 29.
10
Primary Care Physicians' Support of Shared Decision Making for Different Cancer Screening Decisions.初级保健医生对不同癌症筛查决策中共同决策的支持。
Med Decis Making. 2017 Jan;37(1):70-78. doi: 10.1177/0272989X16660547. Epub 2016 Jul 18.

引用本文的文献

1
Influence of life expectancy on shared decision-making for prostate cancer screening.预期寿命对前列腺癌筛查共同决策的影响。
Cancer Causes Control. 2025 Sep 10. doi: 10.1007/s10552-025-02069-1.
2
Shared decision-making before prostate cancer screening decisions.前列腺癌筛查决策前的共同决策。
Nat Rev Urol. 2024 Jun;21(6):329-338. doi: 10.1038/s41585-023-00840-0. Epub 2024 Jan 2.
3
Initial Longitudinal Outcomes of Risk-Stratified Men in Their Forties Screened for Prostate Cancer Following Implementation of a Baseline Prostate-Specific Antigen.
在实施基线前列腺特异性抗原检测后,对40多岁的男性进行前列腺癌风险分层筛查的初步纵向结果。
World J Mens Health. 2023 Jul;41(3):631-639. doi: 10.5534/wjmh.220068. Epub 2022 Aug 16.